Identifying Optimal Candidates for Primary Tumor Resection Among Metastatic Pancreatic Cancer Patients: A Population-Based Predictive Model
Open Access
- 20 April 2024
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 42 (4) , 333-344
Abstract
BackgroundThere is a controversy about whether surgery should proceed among metastatic pancreatic cancer (mPC) patients. A survival benefit was observed in mPC patients who underwent primary tumor resection; however, determining which patients would benefit from surgery is complex. For this purpose, we created a model to identify mPC patients who may benefit from primary tumor excision.MethodsPatients with mPC were extracted from the Surveillance, Epidemiology, and End Results database, and separated into surgery and nonsurgery groups based on whether the primary tumor was resected. Propensity score matching (PSM) was applied to balance confounding factors between the two groups. A nomogram was developed using multivariable logistic regression to estimate surgical benefit. Our model is evaluated using multiple methods.ResultsAbout 662 of 14,183 mPC patients had primary tumor surgery. Kaplan-Meier analyses showed that the surgery group had a better prognosis. After PSM, a survival benefit was still observed in the surgery group. Among the surgery cohort, 202 patients survived longer than 4 months (surgery-beneficial group). The nomogram discriminated better in training and validation sets under the receiver operating characteristic (ROC) curve (AUC), and calibration curves were consistent. Decision curve analysis (DCA) revealed that it was clinically valuable. This model is better at identifying candidates for primary tumor excision.ConclusionA helpful prediction model was developed and validated to identify ideal candidates who may benefit from primary tumor resection in mPC.Keywords
Funding Information
- China Scholarship Council (201908440264)
This publication has 44 references indexed in Scilit:
- Systemic Therapy for Metastatic Pancreatic CancerCurrent Treatment Options in Oncology, 2021
- Practical Guide to Surgical Data Sets: Surveillance, Epidemiology, and End Results (SEER) DatabaseJAMA Surgery, 2018
- Identifying Optimal Candidates for Local Treatment of the Primary Tumor Among Patients Diagnosed with Metastatic Prostate Cancer: A SEER-based StudyEuropean Urology, 2015
- Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based StudyEuropean Urology, 2014
- Tumor heterogeneity: Causes and consequencesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
- Tumor Self-Seeding by Circulating Cancer CellsCell, 2009
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009
- Neoadjuvant Chemotherapy and Radiation for Patients with Locally Unresectable Pancreatic Adenocarcinoma: Feasibility, Efficacy, and SurvivalJournal of Gastrointestinal Surgery, 2008
- Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?Cancer, 2007
- Initial Presentation With Stage IV Colorectal CancerArchives of Surgery, 2000